Treatment
Share your love
VSY Biotechnology: Who Will Shine at the OSA 2024?
VSY Biotechnology GmbH, a leading company with innovative ophthalmic solutions, is now accepting submissions for Ophthalmology Star Awards (OSA) 2024 from eye care professionals worldwide. The awards aim to celebrate and promote novel research and advancements in ophthalmology, with winners…
NVISION Eye Centers Partners with Parkhurst NuVision
NVISION Eye Centers, a prominent provider of eye care services nationwide, announced a strategic collaboration with Parkhurst NuVision of San Antonio, Texas, through its subsidiary NVision Clinical Research, LLC. This partnership aims to advance clinical trials in ophthalmology drug development,…
Notal Vision’s OCT Promises Advances in Wet AMD Management
Notal Vision announced findings from a pioneering clinical trial using home-based optical coherence tomography (OCT) to oversee patients with wet age-related macular degeneration (AMD). Published in Retina, the results highlighted a notable reduction in office visits and treatment frequency, while…
ANI Pharmaceuticals to Acquire Alimera Sciences in $381M Deal
ANI Pharmaceutical has signed a definitive agreement to acquire Alimera at approximately $381 million. The agreement has been approved by both companies’ Boards of Directors and is anticipated to close in the late third quarter of 2024. Alimera Sciences, a…
4DMT Receives FDA Clearance of IND for GA Treatment
4D Molecular Therapeutics (4DMT) announced the FDA clearance of its investigational new drug application (IND) for 4D-175, an R100 vector-based intravitreal genetic medicine intended for treating geographic atrophy (GA) in patients. Phase 1 GAZE Clinical Trial Details The phase 1…
What Is Staphyloma? | OBN
Staphyloma is a bulging or protrusion of the eye’s inner layers through a thinned area of the outer layers. It is typically caused by a structural weakness in the eye, and it can lead to vision problems if left untreated.…
Novartis’ AMD Drug Linked to Rare Retinal Side Effects
Two recent studies have found that a drug called brolucizumab, which was approved in 2019 and developed by Swiss pharmaceutical company Novartis AG to treat wet age-related macular degeneration (AMD), can cause rare retinal side effects due to its interaction…
Use of Telemedicine in Ophthalmology
The medical industry is undergoing radical change as we enter the digital age. One such change is the advent of telemedicine – a powerful tool enabling healthcare providers to connect with patients remotely. Ophthalmology, the branch of medicine dedicated to…
What is Ophthalmology? | OBN
The word itself originates from Greek words phthalmos, “eye” and -logia, “study” and Ophthalmology means “the study of eyes”. Ophthalmology is the branch in medicine that concerns the medical conditions and health of the eyes. The discipline covers all animal…
Vitamin A & The Ocular Surface
Vitamin A deficiency remains an important cause of ocular morbidity among patients with chronic liver disease and lipid malabsorption, and is a major cause of blindness in developing countries. Early ocular surface changes include keratinization of the conjunctiva and development…